Model Number 3CX*RX15RW30 |
Device Problem
Use of Device Problem (1670)
|
Patient Problem
Injury (2348)
|
Event Date 03/02/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, specifically at the time of entry in partial extracorporary circulation, the patient saturation decreased, reaching 70%, noticed that the post oxygenated blood side's coloring was equal to the unsaturated venous return.The amount of blood loss is unknown.Product was changed out.Product was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on march 27, 2018.(b)(4).The actual sample was not returned for evaluation.Retention samples were obtained from products of the same rx15 size as the actual sample that used the same fiber lot numbers.Gas transfer testing was performed on the retention units and were found to meet factory specifications.Review of the device history record confirmed there was no indication of production related anomaly or nonconforming inspection results.Without the actual sample, a definitive root cause can not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|